Literature DB >> 10357818

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins.

O Gires1, F Kohlhuber, E Kilger, M Baumann, A Kieser, C Kaiser, R Zeidler, B Scheffer, M Ueffing, W Hammerschmidt.   

Abstract

Latent membrane protein 1 (LMP1) acts like a permanently activated receptor of the tumor necrosis factor (TNF)-receptor superfamily and is absolutely required for B cell immortalization by Epstein-Barr virus. Molecular and biochemical approaches demonstrated that LMP1 usurps cellular signaling pathways resulting in the induction of NF-kappaB and AP-1 via two C-terminal activating regions. We demonstrate here that a third region encompassing a proline rich sequence within the 33 bp repetitive stretch of LMP1's C-terminus is required for the activation of Janus kinase 3 (JAK3). The interaction of LMP1 and JAK3 leads to the enhanced tyrosine auto/transphosphorylation of JAK3 within minutes after crosslinking of a conditional NGF-R:LMP1 chimera and is a prerequisite for the activation of STAT transcription factors. These results reveal a novel activating region in the LMP1 C-terminus and identify the JAK/STAT pathway as a target of this viral integral membrane protein in B cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357818      PMCID: PMC1171388          DOI: 10.1093/emboj/18.11.3064

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.

Authors:  E Hatzivassiliou; W E Miller; N Raab-Traub; E Kieff; G Mosialos
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

2.  Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells.

Authors:  S H Hanissian; R S Geha
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

3.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

Authors:  F Wang; C Gregory; C Sample; M Rowe; D Liebowitz; R Murray; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.

Authors:  R M Weber-Nordt; C Egen; J Wehinger; W Ludwig; V Gouilleux-Gruart; R Mertelsmann; J Finke
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

6.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

7.  Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Authors:  O Devergne; E Hatzivassiliou; K M Izumi; K M Kaye; M F Kleijnen; E Kieff; G Mosialos
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

8.  Regulation of JAK3 expression and activation in human B cells and B cell malignancies.

Authors:  P J Tortolani; B K Lal; A Riva; J A Johnston; Y Q Chen; G H Reaman; M Beckwith; D Longo; J R Ortaldo; K Bhatia; I McGrath; J Kehrl; J Tuscano; D W McVicar; J J O'Shea
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

9.  All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

Authors:  R K Moorthy; D A Thorley-Lawson
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells.

Authors:  X Xu; S H Kang; O Heidenreich; M Okerholm; J J O'Shea; M I Nerenberg
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more
  105 in total

1.  Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.

Authors:  H Chen; J M Lee; Y Zong; M Borowitz; M H Ng; R F Ambinder; S D Hayward
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.

Authors:  Saparna Pai; Brendan J O'Sullivan; Leanne Cooper; Ranjeny Thomas; Rajiv Khanna
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.

Authors:  Jingwu Xu; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex.

Authors:  A Kaykas; K Worringer; B Sugden
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis.

Authors:  William F Coffin; Timothy R Geiger; Jennifer M Martin
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling.

Authors:  Ajamete Kaykas; Kathleen Worringer; Bill Sugden
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 7.  The expression and function of Epstein-Barr virus encoded latent genes.

Authors:  L S Young; C W Dawson; A G Eliopoulos
Journal:  Mol Pathol       Date:  2000-10

8.  Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.

Authors:  K Sandvej; B S Andresen; X G Zhou; N Gregersen; S Hamilton-Dutoit
Journal:  Mol Pathol       Date:  2000-10

9.  TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

Authors:  Aristides G Eliopoulos; Elyse R Waites; Sarah M S Blake; Clare Davies; Paul Murray; Lawrence S Young
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

Authors:  Jie Yang; Saara Aittomäki; Marko Pesu; Kara Carter; Jussi Saarinen; Nisse Kalkkinen; Elliott Kieff; Olli Silvennoinen
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.